Evaluation of mifepristone as a once a month contraceptive pill
被引:18
作者:
Agarwal, Mukta
论文数: 0引用数: 0
h-index: 0
机构:
CSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, IndiaCSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, India
Agarwal, Mukta
[1
]
Das, Vinita
论文数: 0引用数: 0
h-index: 0
机构:
CSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, IndiaCSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, India
Das, Vinita
[1
]
Agarwal, Anjoo
论文数: 0引用数: 0
h-index: 0
机构:
CSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, IndiaCSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, India
Agarwal, Anjoo
[1
]
Pandey, Amita
论文数: 0引用数: 0
h-index: 0
机构:
CSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, IndiaCSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, India
Pandey, Amita
[1
]
Srivastava, Deepali
论文数: 0引用数: 0
h-index: 0
机构:
CSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, IndiaCSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, India
Srivastava, Deepali
[1
]
机构:
[1] CSM Med Univ, Dept Obstet & Gynaecol, Upgraded King Georges Med Univ, Lucknow, Uttar Pradesh, India
OBJECTIVE: The purpose of this study was to assess the efficacy and safety of mifepristone as a contraceptive pill. STUDY DESIGN: A prospective case-control study was conducted in a tertiary care center of North India. The study group (n = 86) was given 200-mg mifepristone tablets on the 16th day of the menstrual cycle. The control group (n = 92) received combined oral contraceptive (COC) as per protocol. Subjects were followed for drug compliance, satisfaction, side effects, and failure. RESULTS: Acceptability of mifepristone was significantly higher in educated population (P < .001), with fewer side effects (P = .001), good satisfaction (P < .001), and higher compliance rate (P = .05). The oral contraceptive pill group had higher adverse biochemical parameters. CONCLUSION: Mifepristone can be used as a monthly contraceptive pill effectively.